Pharmacokinetic Study With Repeated Doses of Stalevo

NCT00693862 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Orion Corporation, Orion Pharma